A new study published by researchers from Tulane University, New Orleans, adds a new benefit to the debated estrogen therapy.

In certain types of Type 2 Diabetes, cells producing insulin are exhausted and ultimately killed, resulting in insulin deficiency.

Here, the authors describe how Estrogen can prevent the death of the insulin-producing cells by blocking the killer. However, so far these promising results come from experiments in mice. Only clinical studies in human will reveal whether physicians can prescribe estrogen as a treatment for Type 2 Diabetes.